Lauren Badalato

Kingston, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Understanding the impact of genomic secondary findings on clinical care and patient experience: a protocol for a prospective observational study.

Understanding the impact of genomic secondary findings on clinical care and patient experience: a protocol for a prospective observational study.

Journal: BMJ open

Published: March 27, 2026

Early Detection and Therapy of Asymptomatic Group 1 Pulmonary Hypertension Following Genetic Testing: A Case Involving Familial KCNK3 Variants.

Early Detection and Therapy of Asymptomatic Group 1 Pulmonary Hypertension Following Genetic Testing: A Case Involving Familial KCNK3 Variants.

Journal: CJC open

Published: March 20, 2026

Understanding the decision of parents to opt-out of medically actionable secondary findings offered through genome sequencing.

Understanding the decision of parents to opt-out of medically actionable secondary findings offered through genome sequencing.

Journal: Journal of genetic counseling

Published: July 11, 2025

Fetal Presentation of MYRF-Related Cardiac Urogenital Syndrome: An Emerging and Challenging Prenatal Diagnosis.

Fetal Presentation of MYRF-Related Cardiac Urogenital Syndrome: An Emerging and Challenging Prenatal Diagnosis.

Journal: Prenatal diagnosis

Published: July 17, 2024

Adults with paternal UPD14 causing Kagami-Ogata syndrome: Case report and review of the literature.

Adults with paternal UPD14 causing Kagami-Ogata syndrome: Case report and review of the literature.

Journal: American journal of medical genetics. Part A

Published: October 18, 2023

Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study.

Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: April 21, 2023

Bridging clinical care and research in Ontario, Canada: Maximizing diagnoses from reanalysis of clinical exome sequencing data.

Bridging clinical care and research in Ontario, Canada: Maximizing diagnoses from reanalysis of clinical exome sequencing data.

Journal: Clinical genetics

Published: September 25, 2022

Activating RAC1 variants in the switch II region cause a developmental syndrome and alter neuronal morphology.

Activating RAC1 variants in the switch II region cause a developmental syndrome and alter neuronal morphology.

Journal: Brain : a journal of neurology

Published: September 20, 2021

De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.

De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.

Journal: American journal of human genetics

Published: February 25, 2020

Fragile X testing as a second-tier test.

Fragile X testing as a second-tier test.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: September 16, 2017

Third party interpretation of raw genetic data: an ethical exploration.

Third party interpretation of raw genetic data: an ethical exploration.

Journal: European journal of human genetics : EJHG

Published: February 13, 2017

Ethical considerations for genetic testing in the context of mandated cardiac screening before athletic participation.

Ethical considerations for genetic testing in the context of mandated cardiac screening before athletic participation.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: June 14, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026